Assessing risk for cardiovascular disease in patients with human immunodeficiency virus: Why it matters

Circulation. 2010 Feb 9;121(5):620-2. doi: 10.1161/CIR.0b013e3181d2c863. Epub 2010 Jan 25.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / mortality*
  • HIV Infections / drug therapy
  • HIV Infections / mortality*
  • HIV*
  • Humans
  • Risk Factors